PNOC002 - CC #120819: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children and Young Adults with Recurrent/Refractory BRAFV600E- or BRAF Ins T mutant Brain Tumors

  • Fangusaro, Jason R (PD/PI)
  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/16 → 4/30/21

Funding

  • University of California San Francisco
  • Genentech, Inc